Search
Search Results
-
Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol
Prediction of individual ovarian response to exogenous gonadotropin is a cornerstone for success and safety in all controlled ovarian stimulation...
-
Effect of different starting doses of FSH on laboratory and clinical outcomes in patients with moderate AMH level
BackgroundIVF and ICSI-ET are widely used ART for addressing infertility which have been developed and improved over the last four decades. COS is a...
-
Personalizing the first dose of FSH for IVF/ICSI patients through machine learning: a non-inferiority study protocol for a multi-center randomized controlled trial
BackgroundAdequately selecting the initial follicle-stimulating hormone (FSH) dose during controlled ovarian stimulation (COS) is key for success in...
-
Can AMH levels predict the need to step up FSH dose for controlled ovarian stimulation following a long GnRH agonist protocol in PCOS women?
BackgroundTo explore the role of anti-Mullerian hormone (AMH) in predicting the need to step up recombinant FSH (rFSH) dose following long GnRH...
-
Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation
BackgroundSelecting an appropriate and personalized Gn starting dose (GSD) is an essential procedure for determining the quality and quantity of...
-
Optimizing FSH Concentration Modulation in the Short-Acting GnRH-a Long Protocol for IVF/ICSI: A Retrospective Study
IntroductionExogenous gonadotropin (Gn) is given to regulate follicle-stimulating hormone (FSH) levels to achieve optimal ovarian response in in...
-
Value of estrogen pretreatment in patients with diminished ovarian reserve and elevated FSH on a line antagonist regimen: a retrospective controlled study
BackgroundThe key to enhancing the efficacy of antagonistic regimens in pregnancy is to better synchronize follicular growth during cycles of...
-
Algorithm-based individualization methodology of the starting gonadotropin dose in IVF/ICSI and the freeze-all strategy prevent OHSS equally in normal responders: a systematic review and network meta-analysis of the evidence
PurposeOvarian hyperstimulation syndrome (OHSS) represents a rare but dangerous condition associated with controlled ovarian stimulation (COS) in...
-
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017)
BackgroundIndividualization of the follicle-stimulating hormone (FSH) starting dose is considered standard clinical practice during controlled...
-
Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study
IntroductionFor high responders with polycystic ovary syndrome (PCOS), there is no clear recommendation for the initial follicle-stimulating hormone...
-
Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU
ObjectiveNowadays, patients attempting social/elective egg freezing has spread globally. Ovarian stimulation (OS) with high daily gonatotropin doses,...
-
Determining the optimal daily gonadotropin dose to maximize the oocyte yield in elective egg freezing cycles
ObjectiveOvarian stimulation (OS) with high daily gonadotropin doses are commonly offered to patients attempting social/elective egg freezing....
-
FSH versus AMH: age-related relevance to ICSI results
BackgroundWomen’s fecundity is known to decrease with the increase in chronologic age. Several biomarkers of the ovarian reserve, including follicle...
-
Ultra-low–dose and very-low–dose Lupron downregulation protocols for poor responders based on POSEIDON group 3 and 4 classifications
PurposeThe objective of this study was to assess if very-low–dose Lupron (VLDL) and ultra-low–dose Lupron (ULDL) protocols can have comparable cycle...
-
A predictive formula for selecting individual FSH starting dose based on ovarian reserve markers in IVF/ICSI cycles
BackgroundAlthough exogenous follicle-stimulating hormone (FSH) has been used for decades and millions of cycles have been performed worldwide until...
-
Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
BackgroundA “mismatch” sequence of less prenatal weight gain and more postnatal weight gain may lead to ectopic lipid accumulation, and trigger the...
-
Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes
ObjectiveTo determine whether a reduced dose of follicle-stimulating hormone (FSH) before human chorionic gonadotropin (hCG) trigger during ovarian...
-
Prediction of microdissection testicular sperm extraction outcomes of azoospermic patients post-chemotherapy using cyclophosphamide equivalent dose
PurposeWe determined the sperm retrieval rate in men with persistent azoospermia post-chemotherapy in relation to cyclophosphamide equivalent dose...
-
A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study
BackgroundOvarian stimulation during medically assisted reproduction treatment should be individualized to optimize outcomes and reduce...
-
The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial
BackgroundResveratrol is a natural polyphenolic compound present in plants and red wine with many potential health benefits. This compound has...
